On-Demand Biospecimen Collection System

The USPTO published patent application US20260094679A1 filed by inventor Patricia Tawadros for a computer-implemented system enabling secure, de-identified coordination among donors, scientists, and administrators for human biospecimen collection. The platform integrates donor registration, identity verification, scheduling, payment processing, and real-time courier tracking with configurable compensation models.

Medical Card System with UV Code and Embedded Chip for Healthcare Information Management

The USPTO published patent application US20260094681A1 by inventor Richard Schriewer, covering a system for managing patient medical information comprising a medical identity card with multiple data storage layers (visible print, UV-visible code, and embedded chip), a mobile UV reader for healthcare personnel, and a stationary reader with security controls for clinical settings. The system enables tiered access to healthcare data based on sensitivity levels.

Radiology Report Generation Using AI Segmentation and Speech-to-Text

USPTO published patent application US20260094682A1 for a system and method of automatically generating radiology reports using AI. The invention processes medical images through segmentation and classification models, incorporates radiologist speech input converted via NLP, and generates structured reports with annotations. The patent names inventors Nivedha Srinivasan and Mouleeswaran Kumar, with application number 18901905.

Functional Behavior Assessment and Positive Behavior Support Strategy Method and Device

The USPTO published patent application US20260094683A1 for a computer-implemented method and device that administers functional behavior assessment (FBA) and generates positive behavior support (PBS) strategies. The system collects target behavior problems, generates questionnaires, determines probable behavior functions, and creates customized lesson plans. Inventors include Hui-Ting Wang, Jia-Yin Wang, Fang-Yu Lin, and Jia-Chi Liang.

Pupillary biomarkers method assesses psychotropic drug effectiveness

USPTO published patent application US20260094684A1 for a method of assessing psychotropic drug effectiveness using pupillary biomarkers. The method uses a pupilometer to obtain and compare pupillary data before and after drug administration, displaying an output indicating drug effectiveness. Inventors: Kamran Siminou, Claudio Privtera, Jeffrey Oliver. Application No. 18898899.

ALT-803 IL-15 Soluble Fusion Molecules and Methods

The USPTO published patent application US20260092097A1 for ALT-803, a complex of interleukin-15 (IL-15) superagonist mutant and dimeric IL-15 receptor α/Fc fusion protein. The application covers compositions and methods for enhancing immune response against neoplasia (multiple myeloma, melanoma, lymphoma) or viral infections (HIV). Inventors: Hing C. Wong, Peter Rhode, Bai Liu, Xiaoyun Zhu, Kai-Ping Han. Application filed June 25, 2025.

Methods of Recellularizing Tissue Transplant for Improved Transplantability

The USPTO published patent application US20260092253A1 for methods of recellularizing an organ or tissue matrix for improved transplantability. Inventors are Doris A. Taylor and Stefan M. Kren. The application was filed December 9, 2025, under application number 19413394. This publication provides public notice of the pending patent application but does not grant any patent rights.

Phase-Changing Matrix for 3D Organoid Culture with Mesenchymal Stem Cells

The USPTO published Application US20260092254A1 claiming a composition for three-dimensional cell and organoid culture comprising a phase-changing matrix with partially ordered polypeptide encapsulating bone-marrow derived or adipose-derived mesenchymal stem cells. The application was filed on September 21, 2023 (Application No. 19113814). This publication provides public notice of the claimed invention for examination purposes.

Cell Based Assays for Botulinum Neurotoxins Serotype-Specific

USPTO published patent application US20260092255A1 for serotype-specific cell-based assays used in characterizing Clostridia botulinum neurotoxins. The assays utilize genetically modified cells capable of discriminating between different serotypes of clostridium neurotoxins without requiring serotype-specific neutralizing antibodies or competing heavy chains. Inventors: Ward Tucker, Francis Mark Dunning, Tim Piazza. Application No. 18920316.

Pepmixes for Multiviral CTL Generation

USPTO published patent application US20260092256A1 by Baylor College of Medicine covering methods of generating CTLs (cytotoxic T lymphocytes) targeting antigens from multiple viruses. The invention uses peptide mixtures exposed to PBMCs with IL4 and IL7 expansion. Published April 2, 2026, Application No. 19020866.